BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28125865)

  • 21. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
    Berlin Grace VM
    Indian J Cancer; 2009; 46(3):203-7. PubMed ID: 19574671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV infection and its correlation with p53 and Bcl-2 among pregnant mothers and their infants.
    Sen S
    Virus Genes; 2024 Jun; 60(3):263-274. PubMed ID: 38664293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation.
    Ghosh A; M N; Padmanabha N; Kini H
    Iran J Pathol; 2020; 15(4):268-273. PubMed ID: 32944038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology.
    Khazaei S; Izadi B; Mirbahari SG; Madani SH; Malek Khosravi Sh; Emami Alagha M; Sajadimajd S
    Asian Pac J Cancer Prev; 2016 Dec; 17(12):5223-5227. PubMed ID: 28125865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
    Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
    Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
    Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
    Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
    Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
    Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunohistochemical detection of P16 and HPV L1 capsid protein on cell block sections from residual PapSpin liquid-based gynecology cytology specimens as a diagnostic and prognostic tool.
    Haltas H; Bayrak R; Yenidunya S; Yildirim U
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1588-95. PubMed ID: 23111976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P16INK4a as an adjunct marker in liquid-based cervical cytology.
    Sahebali S; Depuydt CE; Segers K; Moeneclaey LM; Vereecken AJ; Van Marck E; Bogers JJ
    Int J Cancer; 2004 Mar; 108(6):871-6. PubMed ID: 14712490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Association of High Risk Human Papillomaviruses in Patients With Cervical Cancer: An Evidence Based Study on Patients With Squamous Cell Dysplasia or Carcinoma for Evaluation of 23 Human Papilloma Virus Genotypes.
    Piroozmand A; Mostafavi Zadeh SM; Madani A; Soleimani R; Nedaeinia R; Niakan M; Avan A; Manian M; Moradi M; Eftekhar Z
    Jundishapur J Microbiol; 2016 Apr; 9(4):e32728. PubMed ID: 27279992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMMUNOHISTOCHEMICAL EXPRESSION OF P16INK4a IN INFLAMMATORY, PRENEOPLASTIC AND NEOPLASTIC CERVICAL LESIONS.
    Gajanin R; Gajanin Ž; Vujković Z; Gajanin V; Gojković Z; Ljubojević V
    Med Pregl; 2015; 68(3-4):85-92. PubMed ID: 26214986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions.
    Sari Aslani F; Safaei A; Pourjabali M; Momtahan M
    Iran J Med Sci; 2013 Mar; 38(1):15-21. PubMed ID: 23645953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.
    Bruni L; Diaz M; Castellsagué X; Ferrer E; Bosch FX; de Sanjosé S
    J Infect Dis; 2010 Dec; 202(12):1789-99. PubMed ID: 21067372
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.